Skip to content
CancerIndex

Publication

The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.

Authors not recorded

Clin Cancer Res2009PMID 19318479stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (3)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 3

Curated evidence

Evidence citing this paper (1)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
19318479
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
NFATC2 Fusion1
(diagnostic)Round Cell Sarcoma with EWSR1-non-ETS FusionDiagnosticCSupports Positive3accepted
EID12591

This landmark study represents the first description of the EWSR1::NFATC2 fusion in Ewing-like sarcomas, leading to the establishment of 'round cell sarcoma with EWSR1-non-ETS fusions' as a new diseas… (full text at CIViC)

PMID 19318479 · Szuhai et al., 2009 · Open in CIViC

civic